{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "as-soon-as-practicable", "type": "definition", "offset": [0, 22]}, {"key": "after-the-effective-date", "type": "clause", "offset": [23, 47]}, {"key": "paper-copy", "type": "clause", "offset": [105, 115]}, {"key": "language-of", "type": "clause", "offset": [131, 142]}, {"key": "all-documents", "type": "clause", "offset": [143, 156]}, {"key": "other-information", "type": "clause", "offset": [166, 183]}, {"key": "possession-and-control", "type": "definition", "offset": [197, 219]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [220, 244]}, {"key": "responsible-for", "type": "clause", "offset": [298, 313]}, {"key": "cost-of", "type": "clause", "offset": [318, 325]}], "snippet": "As soon as practicable after the Effective Date, Acologix shall provide Toray with one (1) electronic or paper copy in the English language of all documents, data or other information in Acologix\u2019 possession and Control as of the Effective Date that constitute Acologix Know How. Acologix shall be responsible for the cost of providing one (1) set of copies only.", "samples": [{"hash": "fRXBkO4eLhj", "uri": "/contracts/fRXBkO4eLhj#initial-technology-transfer", "label": "Development and License Agreement (Acologix, Inc.)", "score": 21.0, "published": true}, {"hash": "DcWcQE5IFm", "uri": "/contracts/DcWcQE5IFm#initial-technology-transfer", "label": "Development and License Agreement (Acologix, Inc.)", "score": 21.0, "published": true}], "size": 2, "hash": "18a25935e2ba57c53363cb316544750f", "id": 7}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [20, 44]}, {"key": "to-practice", "type": "clause", "offset": [144, 155]}, {"key": "granted-to", "type": "definition", "offset": [168, 178]}, {"key": "article-5", "type": "clause", "offset": [188, 197]}, {"key": "emisphere-technology", "type": "definition", "offset": [254, 274]}, {"key": "development-term", "type": "clause", "offset": [367, 383]}, {"key": "technical-assistance", "type": "clause", "offset": [431, 451]}, {"key": "relating-to", "type": "definition", "offset": [452, 463]}, {"key": "to-the-extent", "type": "clause", "offset": [508, 521]}, {"key": "licenses-granted", "type": "clause", "offset": [564, 580]}], "snippet": "Commencing promptly after the Effective Date: (a) Genta shall disclose to Emisphere all existing Genta Technology necessary to enable Emisphere to practice the license granted to it under Article 5; and (b) Emisphere shall disclose to Genta all existing Emisphere Technology necessary to enable Genta to practice the license granted to it under Article 5. During the Development Term, Emisphere shall provide Genta with reasonable technical assistance relating to the use of the Emisphere Technology, solely to the extent necessary to enable Genta to practice the licenses granted to it under Article 5.", "samples": [{"hash": "a4APWfNMLwg", "uri": "/contracts/a4APWfNMLwg#initial-technology-transfer", "label": "Development and License Agreement (Emisphere Technologies Inc)", "score": 21.0, "published": true}, {"hash": "9BmNpZEByA5", "uri": "/contracts/9BmNpZEByA5#initial-technology-transfer", "label": "Development and License Agreement (Genta Inc De/)", "score": 21.0, "published": true}], "size": 2, "hash": "a6da1448d12d874aabc460c0514898e9", "id": 9}, {"snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [32, 60]}, {"key": "the-specifications", "type": "clause", "offset": [100, 118]}, {"key": "manufacturing-process", "type": "definition", "offset": [177, 198]}, {"key": "confidential-treatment-request", "type": "clause", "offset": [262, 292]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [304, 342]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [358, 374]}, {"key": "securities-act-of-1933", "type": "definition", "offset": [389, 411]}, {"key": "the-commission", "type": "clause", "offset": [461, 475]}], "snippet": "As soon as reasonably practical following the Effective Date, Eton shall provide *** with a copy of the Specifications, the anticipated formulation for Product, and the initial manufacturing process for Product. ***Text has been omitted pursuant to Registrant\u2019s confidential treatment request filed with the Securities and Exchange Commission (\u201cCommission\u201d) pursuant to Rule 406 under the Securities Act of 1933. The omitted text has been filed separately with the Commission.", "samples": [{"hash": "eHCmSoTJjOz", "uri": "/contracts/eHCmSoTJjOz#initial-technology-transfer", "label": "Development, Supply and Commercialization Agreement (Eton Pharmaceuticals, Inc.)", "score": 29.7310066223, "published": true}, {"hash": "1XeKwAD5q4x", "uri": "/contracts/1XeKwAD5q4x#initial-technology-transfer", "label": "Development, Supply and Commercialization Agreement (Eton Pharmaceuticals, Inc.)", "score": 29.6050643921, "published": true}], "size": 4, "hash": "afc1130abde6182931be14fc5c67378b", "id": 1}, {"snippet_links": [{"key": "license-date", "type": "definition", "offset": [31, 43]}, {"key": "to-the-extent", "type": "clause", "offset": [83, 96]}, {"key": "available-to", "type": "definition", "offset": [174, 186]}, {"key": "outside-of-the-territory", "type": "clause", "offset": [293, 317]}, {"key": "the-applicable", "type": "clause", "offset": [322, 336]}, {"key": "regulatory-filings", "type": "definition", "offset": [359, 377]}, {"key": "regulatory-documentation", "type": "definition", "offset": [394, 418]}, {"key": "reasonably-necessary", "type": "clause", "offset": [493, 513]}, {"key": "the-development", "type": "clause", "offset": [528, 543]}, {"key": "manufacture-of-the-licensed-product", "type": "clause", "offset": [547, 582]}], "snippet": "Commencing promptly after each License Date for a particular Licensed Product, and to the extent not already provided to TAIHO, Arcus shall provide to TAIHO all existing and available to Arcus (in recorded form) Arcus Know-How that enabled the filing of the IND by or under authority of Arcus outside of the Territory for the applicable Licensed Product, all Regulatory Filings and substantive Regulatory Documentation for the applicable Licensed Product and all other Arcus Know-How which is reasonably necessary or useful for the Development or manufacture of the Licensed Product in or for the Territory.", "samples": [{"hash": "bonT3i9HHEY", "uri": "/contracts/bonT3i9HHEY#initial-technology-transfer", "label": "Option and License Agreement (Arcus Biosciences, Inc.)", "score": 29.1259403229, "published": true}, {"hash": "2IWhGbjg3UZ", "uri": "/contracts/2IWhGbjg3UZ#initial-technology-transfer", "label": "Option and License Agreement (Arcus Biosciences, Inc.)", "score": 29.049282074, "published": true}, {"hash": "gpxcTq2TTeI", "uri": "/contracts/gpxcTq2TTeI#initial-technology-transfer", "label": "Option and License Agreement (Arcus Biosciences, Inc.)", "score": 28.9534568787, "published": true}], "size": 3, "hash": "78bd801bfde54c77795fdbf5efa01b8f", "id": 2}, {"snippet_links": [{"key": "to-the-extent", "type": "clause", "offset": [0, 13]}, {"key": "make-available", "type": "definition", "offset": [106, 120]}, {"key": "site-visits", "type": "definition", "offset": [130, 141]}, {"key": "access-to", "type": "definition", "offset": [145, 154]}, {"key": "licensed-know", "type": "clause", "offset": [201, 214]}, {"key": "relating-to", "type": "definition", "offset": [219, 230]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [270, 297]}, {"key": "in-accordance-with", "type": "clause", "offset": [314, 332]}, {"key": "licenses-granted", "type": "clause", "offset": [337, 353]}, {"key": "section-43", "type": "clause", "offset": [381, 392]}], "snippet": "To the extent not previously provided, within [***] of the Effective Date, Isis will deliver or otherwise make available (through site visits or access to shared electronic portals) to AstraZeneca the Licensed Know-How relating to the [***] Program as conducted by \u2587\u2587\u2587\u2587 prior to the Effective Date, for use solely in accordance with the licenses granted under Section 4.1.1(a) and Section 4.3.", "samples": [{"hash": "7hMGGkEsXt0", "uri": "/contracts/7hMGGkEsXt0#initial-technology-transfer", "label": "Strategic Collaboration Agreement (Ionis Pharmaceuticals Inc)", "score": 36.5756340027, "published": true}, {"hash": "7AmF4p653oI", "uri": "/contracts/7AmF4p653oI#initial-technology-transfer", "label": "Strategic Collaboration Agreement (Ionis Pharmaceuticals Inc)", "score": 27.4394245148, "published": true}, {"hash": "3jW9vRfQShD", "uri": "/contracts/3jW9vRfQShD#initial-technology-transfer", "label": "Strategic Collaboration Agreement (Isis Pharmaceuticals Inc)", "score": 26.8535251617, "published": true}], "size": 3, "hash": "6aa145686704b98ecd6ef17b2e84b4a0", "id": 3}, {"snippet_links": [{"key": "period-of", "type": "definition", "offset": [13, 22]}, {"key": "following-the-effective-date", "type": "clause", "offset": [35, 63]}, {"key": "technology-transfer-period", "type": "clause", "offset": [66, 92]}, {"key": "activities-assigned", "type": "clause", "offset": [123, 142]}, {"key": "technology-transfer-plan", "type": "definition", "offset": [174, 198]}, {"key": "schedule-f", "type": "definition", "offset": [218, 228]}, {"key": "from-time-to-time", "type": "clause", "offset": [251, 268]}, {"key": "mutual-agreement-of-the-parties", "type": "clause", "offset": [272, 303]}, {"key": "no-additional-cost", "type": "clause", "offset": [341, 359]}, {"key": "to-licensee", "type": "definition", "offset": [360, 371]}, {"key": "subject-to", "type": "clause", "offset": [373, 383]}, {"key": "transfer-to", "type": "definition", "offset": [424, 435]}, {"key": "necessary-for", "type": "definition", "offset": [531, 544]}, {"key": "of-licensee", "type": "clause", "offset": [558, 569]}, {"key": "licenses-granted", "type": "clause", "offset": [589, 605]}, {"key": "pursuant-to-section", "type": "definition", "offset": [606, 625]}, {"key": "operation-of-the-facility", "type": "clause", "offset": [645, 670]}, {"key": "the-share-purchase-agreement", "type": "clause", "offset": [756, 784]}, {"key": "available-to", "type": "definition", "offset": [827, 839]}, {"key": "number-of", "type": "definition", "offset": [854, 863]}, {"key": "technical-personnel", "type": "definition", "offset": [864, 883]}, {"key": "by-licensee", "type": "clause", "offset": [1007, 1018]}, {"key": "items-delivered", "type": "clause", "offset": [1034, 1049]}, {"key": "in-connection-with", "type": "clause", "offset": [1083, 1101]}, {"key": "manufacture-of-licensed-products", "type": "clause", "offset": [1159, 1191]}, {"key": "licensee-shall", "type": "clause", "offset": [1290, 1304]}, {"key": "to-transfer", "type": "clause", "offset": [1666, 1677]}, {"key": "the-performance", "type": "clause", "offset": [1678, 1693]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [1747, 1774]}, {"key": "alternate-facility", "type": "clause", "offset": [1781, 1799]}, {"key": "by-alnylam", "type": "clause", "offset": [1836, 1846]}], "snippet": "(i) Within a period of [**] months following the Effective Date (\u201cTechnology Transfer Period\u201d), Alnylam shall complete the activities assigned to Alnylam as set forth on the technology transfer plan attached hereto as Schedule F (as it may be amended from time to time by mutual agreement of the Parties, the \u201cTechnology Transfer Plan\u201d), at no additional cost to Licensee (subject to subsection 3.1(d) below), to effect the transfer to Licensee (or its designated Affiliate(s)) of Licensed Intellectual Property that is reasonably necessary for the exercise of Licensee\u2019s rights under the licenses granted pursuant to Section 2.1(a) and for the operation of the facility in Kulmbach, Germany which is being transferred to Licensee pursuant to the terms of the Share Purchase Agreement (\u201cKulmbach Facility\u201d). Alnylam shall make available to Licensee such number of technical personnel as may be set forth in the Technology Transfer Plan to answer any questions or provide instruction as reasonably requested by Licensee concerning the items delivered pursuant to this Section 3.1(a), in connection with Licensee\u2019s Discovery, Development, Commercialization and Manufacture of Licensed Products hereunder and the operation of the Kulmbach Facility.\n(ii) During the Technology Transfer Period, Licensee shall conduct, and shall cause Licensee\u2019s applicable Affiliate(s) to conduct, the activities assigned to Licensee (and/or its Affiliates) as set forth on the Technology Transfer Plan, at no additional cost to Alnylam, to effect the transfer to Alnylam (or its designated Affiliate(s)) of Know-How which is reasonably necessary to enable Alnylam (or its Affiliate(s)) to transfer the performance of the activities conducted at the Kulmbach Facility prior to the Effective Date to an alternate facility in Cambridge, MA, U.S.A, designated by Alnylam.", "samples": [{"hash": "8Sk3Ami7WJK", "uri": "/contracts/8Sk3Ami7WJK#initial-technology-transfer", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "2E59iC5c6EH", "uri": "/contracts/2E59iC5c6EH#initial-technology-transfer", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "size": 3, "hash": "f87bdb9f4338313fbd443f6fb951b7fb", "id": 4}, {"snippet_links": [{"key": "period-of", "type": "definition", "offset": [42, 51]}, {"key": "six-months", "type": "definition", "offset": [52, 62]}, {"key": "from-the-effective-date", "type": "clause", "offset": [63, 86]}, {"key": "transfer-to", "type": "definition", "offset": [88, 99]}, {"key": "to-aradigm", "type": "clause", "offset": [118, 128]}, {"key": "current-version", "type": "clause", "offset": [143, 158]}, {"key": "reasonably-necessary", "type": "clause", "offset": [270, 290]}, {"key": "licensed-product", "type": "definition", "offset": [396, 412]}], "snippet": "INEX shall, upon Aradigm\u2019s request, for a period of six months from the Effective Date, transfer to or make available to Aradigm the then most-current version of all relevant Know-How to enable Aradigm\u2019s reasonably capable Representatives to understand such Know-How as reasonably necessary to encapsulate Ciprofloxacin using the INEX Liposome Technology, with a goal of delivering the resulting Licensed Product with the AERx Device.", "samples": [{"hash": "4zEMPBwbuke", "uri": "/contracts/4zEMPBwbuke#initial-technology-transfer", "label": "License Agreement (TEKMIRA PHARMACEUTICALS Corp)", "score": 23.0807666779, "published": true}, {"hash": "io8gJpAWh81", "uri": "/contracts/io8gJpAWh81#initial-technology-transfer", "label": "License Agreement (Tekmira Pharmaceuticals Corp)", "score": 22.4182071686, "published": true}], "size": 2, "hash": "d79e6dbe3622d881999aad49ee09aed3", "id": 5}, {"snippet_links": [{"key": "time-periods", "type": "definition", "offset": [11, 23]}, {"key": "technology-transfer-plan", "type": "definition", "offset": [39, 63]}, {"key": "by-the-parties", "type": "clause", "offset": [77, 91]}, {"key": "after-the-effective-date", "type": "clause", "offset": [115, 139]}, {"key": "transfer-to", "type": "definition", "offset": [152, 163]}, {"key": "sole-expense", "type": "definition", "offset": [181, 193]}, {"key": "to-the-extent", "type": "clause", "offset": [201, 214]}, {"key": "technology-agreement", "type": "definition", "offset": [273, 293]}, {"key": "complete-copy", "type": "definition", "offset": [306, 319]}, {"key": "tangible-embodiments", "type": "definition", "offset": [400, 420]}, {"key": "each-case", "type": "definition", "offset": [442, 451]}, {"key": "with-respect-to", "type": "clause", "offset": [467, 482]}, {"key": "licensed-products", "type": "definition", "offset": [487, 504]}, {"key": "date-of", "type": "clause", "offset": [521, 528]}, {"key": "reasonably-request", "type": "definition", "offset": [573, 591]}, {"key": "digital-files", "type": "clause", "offset": [618, 631]}, {"key": "secure-website", "type": "clause", "offset": [637, 651]}, {"key": "by-biogen", "type": "clause", "offset": [688, 697]}], "snippet": "Within the time periods set forth in a technology transfer plan to be agreed by the Parties within sixty (60) days after the Effective Date, AGTC shall transfer to Biogen at AGTC\u2019s sole expense [***], to the extent not already transferred to Biogen under the Manufacturing Technology Agreement, a true and complete copy as reasonably practicable of (a) data embodying any AGTC Know-How and (b) other tangible embodiments of AGTC Know-How, in each case ((a) and (b)), with respect to the Licensed Products existing on the date of such transfer, in such format as Biogen may reasonably request (including by download of digital files to a secure website or e-room designated and controlled by Biogen, to which AGTC has equivalent access).", "samples": [{"hash": "6mr9CLDLMyA", "uri": "/contracts/6mr9CLDLMyA#initial-technology-transfer", "label": "Collaboration and License Agreement (Applied Genetic Technologies Corp)", "score": 29.6926765442, "published": true}, {"hash": "bK0vxHAxHi0", "uri": "/contracts/bK0vxHAxHi0#initial-technology-transfer", "label": "Collaboration and License Agreement (Applied Genetic Technologies Corp)", "score": 26.6892547607, "published": true}], "size": 2, "hash": "cc625e742507385a8ab3e0d57668b07a", "id": 6}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [18, 42]}, {"key": "the-jdc", "type": "clause", "offset": [44, 51]}, {"key": "determine-whether", "type": "clause", "offset": [103, 120]}, {"key": "to-approve", "type": "clause", "offset": [121, 131]}, {"key": "technology-transfer-plan", "type": "definition", "offset": [143, 167]}, {"key": "in-accordance-with", "type": "clause", "offset": [288, 306]}, {"key": "section-54", "type": "clause", "offset": [307, 318]}, {"key": "manufacturing-technology-transfer", "type": "clause", "offset": [320, 353]}, {"key": "in-existence", "type": "definition", "offset": [356, 368]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [369, 393]}, {"key": "reasonably-necessary", "type": "clause", "offset": [569, 589]}, {"key": "the-technology", "type": "definition", "offset": [602, 616]}, {"key": "cost-and-expense", "type": "clause", "offset": [696, 712]}, {"key": "for-clarity", "type": "clause", "offset": [714, 725]}], "snippet": "Within [***] days after the Effective Date, the JDC will prepare and the JSC will review, discuss, and determine whether to approve, a written technology transfer plan setting forth the Arrowhead Know-How (excluding all Arrowhead Manufacturing Know-How, which will be provided to Sarepta in accordance with Section 5.4 (Manufacturing Technology Transfer)) in existence as of the Effective Date to be transferred to Sarepta in a commercially reasonably format and the timelines for such transfer (the \u201cTechnology Transfer Plan\u201d). Arrowhead will undertake all activities reasonably necessary to complete the Technology Transfer Plan, in accordance with the timelines set forth therein, at its sole cost and expense. For clarity, Arrowhead will not be required to create any documentation or data that does not already exist as of the Effective Date.", "samples": [{"hash": "hb0zFtAAE3Q", "uri": "/contracts/hb0zFtAAE3Q#initial-technology-transfer", "label": "Exclusive License and Collaboration Agreement (Arrowhead Pharmaceuticals, Inc.)", "score": 36.1101989746, "published": true}, {"hash": "1YL8HfAjZ3j", "uri": "/contracts/1YL8HfAjZ3j#initial-technology-transfer", "label": "Exclusive License and Collaboration Agreement (Sarepta Therapeutics, Inc.)", "score": 34.1594810486, "published": true}], "size": 2, "hash": "58cb2a181989c9ea109abb9dc78d7100", "id": 8}, {"snippet_links": [{"key": "agreement-of-the-parties", "type": "clause", "offset": [92, 116]}, {"key": "to-licensee", "type": "definition", "offset": [151, 162]}, {"key": "licensed-know", "type": "clause", "offset": [177, 190]}, {"key": "in-existence", "type": "definition", "offset": [195, 207]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [208, 232]}, {"key": "to-the-extent", "type": "clause", "offset": [279, 292]}, {"key": "technology-transfer-plan", "type": "definition", "offset": [310, 334]}, {"key": "by-the-parties", "type": "clause", "offset": [357, 371]}, {"key": "details-of", "type": "clause", "offset": [390, 400]}, {"key": "timing-of", "type": "clause", "offset": [457, 466]}, {"key": "licensee-will", "type": "clause", "offset": [515, 528]}, {"key": "in-the-performance", "type": "clause", "offset": [556, 574]}, {"key": "payment-by-licensee", "type": "clause", "offset": [608, 627]}, {"key": "made-pursuant-to", "type": "clause", "offset": [636, 652]}, {"key": "an-invoice", "type": "clause", "offset": [653, 663]}, {"key": "submitted-by", "type": "clause", "offset": [664, 676]}, {"key": "completion-of", "type": "definition", "offset": [694, 707]}, {"key": "pay-to", "type": "definition", "offset": [774, 780]}, {"key": "undisputed-amounts", "type": "definition", "offset": [792, 810]}, {"key": "invoice-no", "type": "clause", "offset": [829, 839]}, {"key": "days-after", "type": "definition", "offset": [854, 864]}], "snippet": "Within three months of the Effective Date (as such period may be extended by mutual written agreement of the Parties), Eureka will complete a transfer to Licensee of the Eureka Licensed Know-How in existence as of the Effective Date (excluding any Eureka Manufacturing Know-How) to the extent described in the technology transfer plan to be mutually agreed by the Parties setting forth the details of such Eureka Licensed Know-How to be transferred and the timing of such transfer (the \u201cTechnology Transfer Plan\u201d). Licensee will reimburse Eureka for [***] in the performance of the Technology Transfer Plan. Payment by Licensee will be made pursuant to an invoice submitted by Eureka following completion of its performance of the Technology Transfer Plan and Licensee will pay to Eureka all undisputed amounts set forth in such invoice no later than 30 days after Licensee\u2019s receipt thereof.", "samples": [{"hash": "2EBqt9kjMRx", "uri": "/contracts/2EBqt9kjMRx#initial-technology-transfer", "label": "License Agreement (TradeUP Acquisition Corp.)", "score": 34.4538002014, "published": true}, {"hash": "3ttkxJvwaqp", "uri": "/contracts/3ttkxJvwaqp#initial-technology-transfer", "label": "License Agreement (TradeUP Acquisition Corp.)", "score": 33.7939758301, "published": true}], "size": 2, "hash": "547c76cf1e7806b7675c2de676ca7972", "id": 10}], "next_curs": "CmQSXmoVc35sYXdpbnNpZGVyY29udHJhY3RzckALEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IiRpbml0aWFsLXRlY2hub2xvZ3ktdHJhbnNmZXIjMDAwMDAwMGEMogECZW4YACAA", "clause": {"title": "Initial Technology Transfer", "parents": [["technology-transfer", "Technology Transfer"], ["development-and-registration", "Development and Registration"], ["records-reports-information-sharing", "Records Reports Information Sharing"], ["information-exchange-and-assistance", "Information Exchange and Assistance"], ["licenses-and-exclusivity", "Licenses and Exclusivity"]], "children": [["transfer-of-manufacturing-technology", "Transfer of Manufacturing Technology"], ["transfer-of-inventory-and-other-materials", "Transfer of Inventory and Other Materials"], ["gal-9-licensed-program", "Gal-9 Licensed Program"], ["other-licensed-programs", "Other Licensed Programs"], ["regulatory-data", "Regulatory Data"]], "size": 63, "id": "initial-technology-transfer", "related": [["technology-transfer", "Technology Transfer", "Technology Transfer"], ["manufacturing-technology-transfer", "Manufacturing Technology Transfer", "Manufacturing Technology Transfer"], ["technology-license", "Technology License", "Technology License"], ["technology-research-analyst-job", "Technology Research Analyst Job#", "Technology Research Analyst Job#"], ["new-technology", "New Technology", "New Technology"]], "related_snippets": [], "updated": "2026-03-19T05:56:49+00:00"}, "json": true, "cursor": ""}}